- Home
- PRME vs BVS Comparison
PRME vs BVS Comparison
Compare PRME & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | BVS |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 617.1M |
| IPO Year | 2022 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PRME | BVS |
|---|---|---|
| Price | $3.42 | $9.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $7.56 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 2.1M | 409.8K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.18 | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | $4,632,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $12.41 | $7.52 |
| Revenue Next Year | $52.24 | $7.06 |
| P/E Ratio | ★ N/A | $27.56 |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $1.11 | $5.81 |
| 52 Week High | $6.94 | $9.53 |
Technical Indicators
Market Signals| Indicator | PRME | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 52.39 |
| Support Level | $3.17 | $8.43 |
| Resistance Level | $3.94 | $9.01 |
| Average True Range (ATR) | 0.25 | 0.33 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 47.17 | 47.33 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.